These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9444051)

  • 1. Effect of the levonorgestrel-releasing intrauterine system on the uterine artery pulsatility index in postmenopausal hormone replacement therapy.
    Järvelä I; Raudaskoski T; Tekay A; Jouppila P
    Ultrasound Obstet Gynecol; 1997 Nov; 10(5):350-5. PubMed ID: 9444051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term treatment with levonorgestrel does not antagonize the ethinyl estradiol-induced increase of uterine blood flow in postmenopausal women.
    Entezami M; Heger-Mahn D; Ebert A; Halis G; Lübbert H
    Contraception; 1997 Sep; 56(3):181-3. PubMed ID: 9347210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of a levonorgestrel-releasing intrauterine system on uterine artery blood flow, hormone concentrations and ovarian cyst formation in fertile women.
    Järvelä I; Tekay A; Jouppila P
    Hum Reprod; 1998 Dec; 13(12):3379-83. PubMed ID: 9886518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous combined parenteral estrogen substitution and intrauterine progestogen delivery: the ideal HST combination?
    Wildemeersch D; Janssens D; Weyers S
    Maturitas; 2005 Jun; 51(2):207-14. PubMed ID: 15917162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial safety after 5 years of continuous combined transdermal estrogen and intrauterine levonorgestrel delivery for postmenopausal hormone substitution.
    Wildemeersch D; Pylyser K; De Wever N; Pauwels P; Tjalma W
    Maturitas; 2007 Jun; 57(2):205-9. PubMed ID: 17227699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of the levonorgestrel-releasing intrauterine system and the copper intrauterine device on subendometrial microvascularization and uterine artery blood flow.
    Jiménez MF; Arbo E; Vetori D; de Freitas FM; Cunha-Filho JS
    Fertil Steril; 2008 Nov; 90(5):1574-8. PubMed ID: 18191844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The temporal effect of progestogen on uterine artery pulsatility index in postmenopausal women receiving sequential hormone replacement therapy.
    Marsh MS; Bourne TH; Whitehead MI; Collins WP; Campbell S
    Fertil Steril; 1994 Oct; 62(4):771-4. PubMed ID: 7926085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequentially combined hormone replacement therapy reduces impedance to flow within the uterine and central retinal arteries in healthy postmenopausal women.
    van Baal WM; Kenemans P; Stehouwer CD; Peters-Muller ER; van Vugt JM; van der Mooren MJ
    Am J Obstet Gynecol; 1999 Dec; 181(6):1365-73. PubMed ID: 10601914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the effects of intrauterine progestin system and oral progestin on health-related quality of life and Kupperman index in hormone replacement therapy.
    Pirimoglu ZM; Ozyapi AG; Kars B; Buyukbayrak EE; Solak Y; Karsidag AY; Unal O; Turan MC
    J Obstet Gynaecol Res; 2011 Oct; 37(10):1376-81. PubMed ID: 21599801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of estrogen replacement therapy with or without concomitant nonsteroidal anti-inflammatory drugs on pulsatility and resistance index of uterine arteries in healthy postmenopausal women.
    Rozenberg S; Twagirayezu P; Vyankadondera J; Hotimsky A; Van Rysselberge M
    Int J Fertil Womens Med; 1997; 42(4):240-4. PubMed ID: 9309457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal HRT and Doppler findings in normotensive and hypertensive postmenopausal patients.
    Persico N; Mancini F; Artini PG; de Iaco P; Volpe A; de Aloysio D; Battaglia C
    Ultrasound Obstet Gynecol; 2005 Oct; 26(5):546-51. PubMed ID: 16184506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The acceptability of a small intrauterine progestogen-releasing system for continuous combined hormone therapy in early postmenopausal women.
    Sturdee DW; Rantala ML; Colau JC; Zahradnik HP; Riphagen FE;
    Climacteric; 2004 Dec; 7(4):404-11. PubMed ID: 15799612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrauterine and subdermal progestin administration in postmenopausal hormone replacement therapy.
    Suhonen SP; Holmström T; Allonen HO; Lähteenmäki P
    Fertil Steril; 1995 Feb; 63(2):336-42. PubMed ID: 7843440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transvaginal color Doppler sonographic assessment of uterus and ovaries in postmenopausal women: the effect of local estrogen treatment.
    Manonai J; Chittacharoen A; Theppisai U
    Eur J Obstet Gynecol Reprod Biol; 2006 Aug; 127(2):222-6. PubMed ID: 16513246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hormone replacement therapy on postmenopausal uterine myoma.
    Colacurci N; De Franciscis P; Cobellis L; Nazzaro G; De Placido G
    Maturitas; 2000 May; 35(2):167-73. PubMed ID: 10924843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial safety with a low-dose intrauterine levonorgestrel-releasing system after 3 years of estrogen substitution therapy.
    Wildemeersch D; Schacht E; Wildemeersch P; Calleweart K; Pylyser K; De Wever N
    Maturitas; 2004 May; 48(1):65-70. PubMed ID: 15223110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment with vaginal estradiol tablets--an impact on uterine artery blood flow.
    Dmitrovic R; Klobucar A; Bauman R; Cvitkovic-Kuzmic A; Skalko D; Sonicki Z
    Maturitas; 2005 Apr; 50(4):300-4. PubMed ID: 15780530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal uterine arterial blood flow in postmenopausal women assessed by transvaginal color Doppler sonography: the effect of hormone replacement therapy.
    Bonilla-Musoles F; Martí MC; Ballester MJ; Raga F; Osborne NG
    J Ultrasound Med; 1995 Jul; 14(7):497-501. PubMed ID: 7563296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.